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Background: One of the suggest strategy for patients with repeated implantation failure (RIF) is zygote
intrafallopian transfer (ZIFT). However, no data exist regarding to the issue of when and under which circumstances
should ZIFT be offered to patients with RIF? We therefore aimed to examine whether repeated implantation failure
(RIF) patients characteristics or their previous controlled ovarian hyperstimulation (COH) variables may differentiate
between those who will conceive following a ZIFT cycle and those who will not.
Methods: Forty seven consecutive women admitted to our IVF unit during a 7 year period, who underwent
ZIFT for RIF, were included. Ovarian stimulation characteristics, number of oocytes retrieved and number and
quality of zygotes/embryos transferred were assessed and compared between the ZIFT cycle and the previous
IVF/ICSI cycle and between those who conceived following the ZIFT cycle and those who did not.
Results: Twelve clinical pregnancies (clinical pregnancy rate- 25.5%) were recorded following the ZIFT cycle.
Those who benefit from ZIFT were young patients (≤31 yrs), who underwent ≤6 cycle attempts, yielding over
eight 2PN embryos with low (≤0.4) ratio of number of top-quality embryos to total 2PN embryos. Moreover, in
those destined for a ZIFT cycle, only those with >7 2PN embryo should undergo a transfer of at least five 2PN
embryos.
Conclusions: Further large prospective studies are needed to identify the specific characteristics of RIF women
who may benefit from ZIFT.
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Controlled ovarian hyperstimulation (COH) is considered
a key factor in the success of in vitro fertilization-embryo
transfer (IVF-ET) [1]. However, despite the great improve-
ments in ovarian stimulation protocols and fertilization
procedures, implantation rates per embryo remain at ap-
proximately 15% and many couples are still left frustrated
following multiple failed attempts [2].
While analyzing a data from 78,325 cycles in 34,430
women registered in the Human Fertilisation and
Embryology Authority data base, Templeton and Morris
[3] found that four or more previous IVF cycle attempts* Correspondence: raoul.orvieto@sheba.health.gov.il
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stated.significantly reduced both the odds of a birth and the odds
of multiple births. Meldrum et al. [4] analyzed the data
from the 1994 ASRM/SART registry and found that cycle
rank 4 or more demonstrated a significant reduction in
delivery rate. Moreover, while combining their results with
those of previous studies, they demonstrated a modest re-
duction of successful outcome with increasing previous
cycle failures. Recently, in an attempt to examine whether
and when conception may be achieved in multiple re-
peated IVF cycles, we conducted a survey of the outcome
of IVF in 2760 consecutive cycles in our unit. In accord-
ance with the aforementioned studies, we also observed a
significant decreased in pregnancy rate beyond the 3rd IVF
cycle attempt, with no significant decrease between the 4th
to the 20th attempt [5].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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those after failure of three cycles in which reasonably
good embryos were transferred [6], a comprehensive in-
vestigation and many therapeutic strategies were offered.
Counseling couples with RIF remains, therefore, one of
the most frustrating, but rather challenging issue for the
fertility specialists. While many strategies were offered
for the treatment of RIP, including hysteroscopy, endo-
metrial injury, change in the stimulation protocol,
blastocyst transfer, assisted hatching, preimplantation
genetic screening for aneuploidy, etc. [6-8], no compel-
ling advantage for one protocol over another has been
hitherto established [6].
One of the suggest strategy for patients with RIP is zyg-
ote intrafallopian transfer (ZIFT) [9-13]. This procedure,
that was primarily advocated for non tubal factor infertil-
ity, offers the appropriate physiological environment for
the growing zygote/embryo (avoiding the in vitro culture
systems), with an optimal synchronization between em-
bryonic and endometrial development. Moreover, since
it prevents intrauterine manipulation and the consequent
possible embryo expulsion secondary to sub-endometrial/
myometrial contractions, it was also offered to patients
with RIF.
Prompted by these findings, we sought to examine
whether patients characteristics or previous COH vari-
ables may differentiate between those who will conceive
following a ZIFT cycle and those who will not. This will
aid both fertility specialists’ counseling and their patients
in adjusting the appropriate treatment strategy for RIP.
Methods
We reviewed the computerized files of all consecutive
women admitted to our IVF unit during a 7 year period,
who reached the ovum pick-up (OPU) stage. Only
patients undergoing ZIFT were included. The study was
approved by our institutional review board.
All the usual indications for IVF/ICSI and accepted pro-
tocols for ovarian stimulations were included. The selec-
tion of type of COH protocol used was the decision of the
treating physician and largely dependent on the fashion at
the time. In all protocols, gonadotropins were adminis-
tered in variable doses, depending on patient age and/or
ovarian responsiveness in previous cycles, and further
adjusted according to serum E2 levels and vaginal ultra-
sound measurements of follicular diameter obtained
every 2 or 3 days. Routine IVF or intracytoplasmic sperm
injection (ICSI) was performed, as appropriate. ZIFT was
performed 24 hours after ovum pick-up (OPU), and all
patients received luteal support with progesterone.
Data on patient age and infertility-treatment-related
variables were collected from the files. Ovarian stimula-
tion characteristics, number of oocytes retrieved and
number and quality of zygotes/embryos transferred wereassessed and compared between the ZIFT cycle and
the previous IVF/ICSI cycle and between those who
conceived following the ZIFT cycle and those who did
not. Embryos classification was based on the individual
embryo scoring parameters according to pre-established
definitions [14]. A top-quality embryo (TQE) was defined
as seven or more blastomeres on day 3, equally-sized
blastomeres and 20% fragmentation. Clinical pregnancy
was defined as visualization of a gestational sac and fetal
cardiac activity on transvaginal ultrasound.
Results are presented as means ± standard deviations.
Differences in variables were statistically analyzed stu-
dent’s t-test and chi-square test, as appropriate. Operat-
ing Characteristic (ROC) curve analysis was applied to
all continuous quantitative variables. A p value of less
than 0.05 was considered significant.
Results
Forty seven patients undergoing their first ZIFT cycle
were evaluated. Patients underwent their 10.2 ± 2.9 IVF
cycle attempts during the study cycle (range, 6–19) and
their mean age was 33.6 ± 4.9 years. The causes of
infertility and the clinical characteristics of the IVF cycle
which preceded the ZIFT cycle, in the all group and in
those who did or did not conceive following the ZIFT
cycle, are shown in Table 1.
When comparing the COH variable during the cycle
preceding the ZIFT cycle, while there were no in-
between group differences in the COH protocol used,
the mean daily number of gonadotropin ampoules ad-
ministered, peak estradiol levels, the number of oocytes
retrieved, the number of TQE, or the number of
embryos transferred, a trend toward a higher number of
2 pronuclei (PN) embryos was observed in those who
conceived compared to those who did not (8.36 ± 6.07 vs
5.59 ± 3.36; p = 0.06), in the following ZIFT cycle. More-
over, a non-significant (p = 0.2) lower ratio of number of
TQE to total 2PN embryos was observed in those
who conceived (13.9 + 16.1 vs 27.9 + 33.7, respectively;
p = 0.2).
Twelve clinical pregnancies (clinical pregnancy rate-
25.5%) were recorded following the ZIFT cycle, com-
pared to none in the previous IVF cycle. However, it
should be emphasized that the increased pregnancy rate
in the ZIFT cycle is biased owing to the study design,
which offered this approach to patients with RIF who
had failed a previous IVF attempts.
When comparing the COH variable during the
ZIFT cycle, there were no in-between group differences
(Table 2), except for higher number of 2PN embryos in
patients who conceived, compared to those who did not
(8.45 ± 4.4 vs 5.9 ± 2.1; p < 0.01) and a non-significant
higher fertilization rate (61 ± 17 vs 53 ± 18, respectively;
p = 0.18).
Table 1 Comparison between the previous IVF cycles- related variables in patients who conceived and those who did
not following ZIFT
All Non pregnant Pregnant p values
Number of cycles 47 35 12
Patients’ age (years) 33.6 ± 4.9 34.2 ± 4.8 31.9 ± 5.0 ns
Cycle rank 10.2 ± 2.9 10.2 ± 3.0 9.5 ± 3.3 ns
Cause of infertility (% of all)
Male 64.4% 63.6% 66.6% ns
Oligo/anovulation 8.9% 9.1% 8.3% ns
Others 26.6% 27.2% 25% ns
COH protocol (% of all)
Long agonist 63% 62.5% 63.6% ns
Short agonist 11.5% 12.5% 9.1% ns
Antagonist 25.5% 25% 27.2% ns
Mean number of daily gonadotropin ampoules used 3.6 ± 1.5 3.8 ± 1.6 3.1 ± 1.1 p = 0.2
Peak E2 levels on day of hCG administration (pg/ml) 1984 ± 673 1951 ± 624 1937 ± 829 ns
Number of oocytes retrieved 11.1 ± 4.0 10.7 ± 4.4 11.9 ± 6.3 ns
Fertilization rate (%) 55 ± 21 50 ± 21 55 ± 33 ns
Number of 2PN 6.3 ± 4.3 5.6 ± 3.4 8.4 ± 6.1 p = 0.06
Total number of top quality 1.4 ± 1.9 1.6 ± 2.1 1.0 ± 1.5 NS
Embryos (TQE)
Ratio of number of TQE to 2PN 24.5 ± 30.9 27.9 ± 33.7 13.9 ± 16.1 p = 0.2
Number of embryos transferred 2.9 ± 0.9 2.9 ± 1.0 3.0 ± 0.7 ns
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all the continuous quantitative variables did not reach
statistically significant discriminatory value (Table 3),
probably due to the small sample size, except for the
number of 2PN achieved at the ZIFT cycle (>7, p < 0.05).
Given the limitation above, it seems that patients who
may benefit from ZIFT are young patients (≤31 yrs),Table 2 Comparison between the ZIFT cycles- related
variables in patients who conceived and those who did not
Non pregnant Pregnant p values
Number of cycles 35 12
COH protocol (% of all)
Long agonist 61.8% 60% ns
Short agonist 23.5% 10% ns
Antagonist 14.7% 30% ns
Mean number of daily
gonadotropin ampoules used
3.7 ± 1.5 3.0 ± 0.9 ns
Peak E2 levels on day of hCG
administration (pg/ml)
2062 ± 962 1952 ± 628 ns
Number of oocytes retrieved 11.8 ± 4.5 13.3 ± 6.5 ns
Fertilization rate (%) 53 ± 18 61 ± 17 p = 0.18
Number of 2PN 5.9 ± 2.1 8.45 ± 4.4 p < 0.01
Number of 2PN transferred 4.5 ± 1.1 4.7 ± 0.9 nswho underwent ≤6 cycle attempts, yielding over eight
2PN embryos and ≤2 TQE, with low (≤0.4) ratio of
number of TQE to total 2PN embryos. Moreover, in
those destined for a ZIFT cycle, only those with >7 2PN
embryo should undergo a transfer of at least five 2PN
embryos.
Discussion
In the present study, patients with repeated IVF failures
undergoing ZIFT, demonstrated an improved outcome
with reasonable clinical pregnancy rate (PR) (25.5%).
Moreover, although the hitherto published data does not
provide any clear discriminatory criteria to aid selecting
those RIF patients who will benefit from ZIFT, according
to our experience, ZIFT should be offered to those
patients with up to 6 IVF cycle failures, yielding over 8
2PN embryos with ≤2 TQE and that following the COH
for the ZIFT cycle obtained at least 8 2PN.
Levran et al. [9] evaluated the efficacy of ZIFT on
implantation and pregnancy rates in patients with
repeated failure of implantation in IVF-ET cycles. Data
on 70 patients who underwent 92 ZIFT cycles were
compared to a control group consisting of patients with
the same selection criteria who underwent an additional
standard IVF-ET cycle during the same time period. The
implantation and pregnancy rates (8.7%% and 34.2%,
Table 3 ROC analysis for COH variables in the previous IVF and the ZIFT cycles
Variable Cut off Sensitivity Specificity p-value
Previous IVF cycle
Number of cycles ≤6 27.2 96.435 ns
Patients’ age (years) ≤31 58.3 71.4 ns
Mean number of daily gonadotropin ampoules used ≤3.5 90.9 41.9 ns
Peak E2 levels on day of hCG administration (pg/ml) ≤1656 54.5 64.5 ns
Number of 2PN >8 54.5 90.6 ns
Total number of top quality ≤2 91.6 28.1 ns
Embryos (TQE)
Ratio of number of TQE to 2PN ≤0.41 100.0 25.0 ns
Number of embryos transferred >2 75.0 33.3 ns
ZIFT cycle
Mean number of daily gonadotropin ampoules used ≤4 100 28.5 ns
Peak E2 levels on day of hCG administration (pg/ml) ≤2370 81.8 42.8 ns
Number of 2PN >7 63.6 74.2 <0.05
Number of 2PN transferred >4 75.0 48.5 ns
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than in the control group. Moreover, in contrary to our
observation, patients who persistently had low-quality
embryos in previous IVF-ET cycles had relatively low
PRs per transfer in the ZIFT cycles, as compared to
those with better quality embryos.
Since ZIFT is supposed to improve the physiological
environment for the growing zygote/embryo and to offer
optimal conditions for embryonic development, those
who might benefit from the procedure are patients with
poor in-vitro embryo development. The observation by
Levran et al. [9], together with their later study [10] that
demonstrated significantly higher implantation and preg-
nancy rate in patients with RIF undergoing ZIFT as com-
pared to extended culture with blastocyst stage transfer,
actually contradict the aforementioned assumption.
In a recently published updated data from the
same group, Weissman et al. [13] have summarized their
experience with 280 laparoscopic ZIFT. They achieved
96 clinical pregnancies per attempt (34.3%) and 72 live
births (25.7%). However, when referring to the issue of
when and under which circumstances should ZIFT be
offered to patients with RIF? they could not provide any
prerequisite criteria. They concluded that whenever
a thorough evaluation revealed no clear and treatable
reason and the following therapeutic interventions i.e.
mechanical irritation of the endometrium; preimplanta-
tion genetic screening; assisted hatching; co-culture;
intracytoplasmic morphologically selected sperm injec-
tion; and blastocyst transfer failed to achieve pregnancy,
ZIFT could be the next step.
According to our experience, ZIFT should be offered
to young RIF patients (≤31 yrs), who underwent ≤6 cycleattempts, and who achieved over eight 2PN embryos with
low (≤0.4) ratio of number of TQE to total 2PN embryos
in their previous IVF-ET cycle. Moreover, in those des-
tined for a ZIFT cycle, only those with >7 2PN embryo
should undergo a transfer of at least five 2PN embryos,
otherwise, a trans cervical ET should be undertaken.
Of notice, in contrary to Levran et al. [9,10], Aslan et al.
[11] failed to demonstrate significant benefits from ZIFT
procedure over IVF-ET in patients with repeated implant-
ation failure, observation that was in agreement with
Habana and Palter [12], who conducted a meta-analysis,
demonstrating similar pregnancy and implantation rates
in ZIFT and IVF-ET groups. These observations probably
reflect a selection bias, resulting from the nowadays no
established criteria for ZIFT.
Conclusions
Repeated implantation failure patients who underwent
≤6 cycle attempts, yielding over eight 2PN embryos, with
low (≤0.4) ratio of number of top-quality embryos to
total 2PN embryos, may benefit from ZIFT. Further
large prospective studies are needed to elucidate the role
of this approach in patients with repeated IVF failures
patients and to identify the specific characteristics of
women that will aid both fertility specialists’ counseling
and their patients in adjusting the appropriate infertility
treatment.
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